Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

FENC

Fennec Pharmaceuticals Inc

Dec 20 • 04:00PM ET

5.99

Dollar change +0.15
Percentage change 2.57	%

Healthcare • Biotechnology • USA • NASD

Peers: VRTX BMRN ALNY SRPT AGEN XOMA ACAD NBIX PRQR IONS

| Held by: VTI IWM IWN VTWO IWC IWO RSSL VTWV UWM VTWG

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.10	Insider Own	16.44%	Shs Outstand	27.42M	Perf Week	-0.99%
Market Cap	164.31M	Forward P/E	37.44	EPS next Y	0.16	Insider Trans	-0.52%	Shs Float	22.92M	Perf Month	29.09%
Income	-1.13M	PEG	-	EPS next Q	0.16	Inst Own	54.82%	Short Float	9.18%	Perf Quarter	17.22%
Sales	49.35M	P/S	3.33	EPS this Y	137.00%	Inst Trans	12.52%	Short Ratio	17.48	Perf Half Y	-5.67%
Book/sh	-0.19	P/B	-	EPS next Y	-27.93%	ROA	-2.91%	Short Interest	2.10M	Perf Year	-42.29%
Cash/sh	1.47	P/C	4.08	EPS next 5Y	-	ROE	-	52W Range	3.96 - 11.92	Perf YTD	-46.61%
Dividend Est.	-	P/FCF	6.94	EPS past 5Y	-2.95%	ROI	-4.61%	52W High	-49.75%	Beta	0.35
Dividend TTM	-	Quick Ratio	7.64	Sales past 5Y	236.90%	Gross Margin	93.52%	52W Low	51.26%	ATR (14)	0.39
Dividend Ex-Date	-	Current Ratio	7.80	EPS Y/Y TTM	94.99%	Oper. Margin	3.41%	RSI (14)	57.60	Volatility	6.38% 8.27%
Employees	29	Debt/Eq	-	Sales Y/Y TTM	278.09%	Profit Margin	-2.30%	Recom	1.00	Target Price	12.69
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	-198.43%	Payout	-	Rel Volume	1.44	Prev Close	5.84
Sales Surprise	-22.38%	EPS Surprise	-133.33%	Sales Q/Q	7.05%	Earnings	Nov 07 BMO	Avg Volume	120.31K	Price	5.99
SMA20	0.23%	SMA50	17.81%	SMA200	-10.70%	Trades		Volume	172,912	Change	2.57%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-22-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$9 → $12
Sep-07-22	Initiated	CapitalOne	Overweight	$11
Aug-08-22	Resumed	Craig Hallum	Buy	$14
Jun-05-20	Initiated	Cantor Fitzgerald	Overweight	$18
Oct-11-18	Initiated	Goldman	Buy

Dec-20-24 06:16AM	Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales (GlobeNewswire)
Dec-19-24 06:13AM	Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management (GlobeNewswire)
Dec-12-24 07:01AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conference (GlobeNewswire)
Nov-13-24 06:27AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conference (GlobeNewswire) +5.91%
Nov-09-24 02:00AM	Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
06:13AM	Loading…
Nov-07-24 06:13AM	Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) -11.92%
Oct-31-24 06:23AM	Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-28-24 06:23AM	Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth (GlobeNewswire) +11.56%
Sep-05-24 06:56AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-14-24 01:57AM	Q2 2024 Fennec Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -8.89%
Aug-13-24 06:05AM	Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) -6.40%
Aug-06-24 04:31PM	Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024 (GlobeNewswire)
Aug-05-24 06:26AM	Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director (GlobeNewswire)
Jul-29-24 06:15AM	3 Dirt-Cheap Stocks Under $10 That Could EXPLODE! (InvestorPlace)
Jul-15-24 08:32AM	Implied Volatility Surging for Fennec (FENC) Stock Options (Zacks)
06:00AM	Loading…
Jul-01-24 06:00AM	Fennec Pharmaceuticals Announces Management Change (GlobeNewswire)
Jun-25-24 04:35PM	Fennec Announces Results of Annual Meeting (GlobeNewswire)
May-15-24 08:44AM	HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating (MT Newswires)
May-14-24 10:53AM	FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) -26.75%
07:20AM	Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue (MT Newswires)
06:03AM	Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-07-24 06:15PM	Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire)
Apr-23-24 08:01AM	Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing (MT Newswires)
Apr-05-24 07:00PM	Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-27-24 07:00PM	Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-26-24 01:00AM	Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC) (GuruFocus.com)
Mar-22-24 09:49AM	Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:04AM	Q4 2023 Fennec Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-21-24 02:52PM	FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
06:00AM	Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
10:14AM	Loading…
Mar-19-24 10:14AM	Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up (Zacks)
06:01AM	Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024 (GlobeNewswire)
Mar-17-24 09:00PM	Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand (GlobeNewswire)
Feb-29-24 07:04AM	Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Feb-01-24 05:55AM	FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin (GlobeNewswire)
Jan-06-24 03:01AM	Insider Sell: CFO Robert Andrade Sells 30,000 Shares of Fennec Pharmaceuticals Inc (GuruFocus.com)
Dec-05-23 05:55AM	Fennec Announces Incremental $5 Million Investment from Petrichor (GlobeNewswire)
Nov-09-23 04:50PM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-07-23 09:40AM	Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript (Insider Monkey)
02:10AM	Q3 2023 Fennec Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 05:59AM	Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +15.36%
Oct-30-23 06:45AM	Fennec Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 6, 2023 (GlobeNewswire)
Sep-07-23 05:59AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-10-23 12:53PM	Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-03-23 05:59AM	Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) -7.29%
Jul-31-23 05:30AM	Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023 (GlobeNewswire) +8.66%
Jun-12-23 05:00PM	Fennec Announces Results of Annual Meeting (GlobeNewswire)
Jun-08-23 02:53PM	Retail investors who hold 38% of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) gained 13%, institutions profited as well (Simply Wall St.)
Jun-06-23 05:44AM	Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients (GlobeNewswire)
May-11-23 06:01AM	Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-08-23 06:15AM	Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023 (GlobeNewswire)
Apr-28-23 09:26AM	When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Become Profitable? (Simply Wall St.)
Apr-01-23 08:12AM	Investors in Fennec Pharmaceuticals (NASDAQ:FENC) have made a notable return of 52% over the past three years (Simply Wall St.)
Mar-31-23 08:03AM	Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients (GlobeNewswire)
Mar-30-23 05:55AM	Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial Results (GlobeNewswire)
Mar-24-23 06:30AM	7 Biotech Stocks Sitting in the Sweet Spot (InvestorPlace)
Feb-23-23 08:44AM	Why Earnings Season Could Be Great for Adherex Technologies (FENC) (Zacks)
Jan-31-23 06:00AM	Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA (GlobeNewswire) +6.26%
Jan-25-23 07:19AM	Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric Patients (GlobeNewswire) +8.27%
Jan-23-23 11:57AM	RTP drugmaker Fennec sues Cipla over generics effort (American City Business Journals)
Dec-17-22 09:55AM	Institutions own 28% of Fennec Pharmaceuticals Inc. (NASDAQ:FENC) shares but individual investors control 55% of the company (Simply Wall St.)
Nov-11-22 07:10AM	Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Nov-01-22 10:28AM	Fennec Pharmaceuticals Inc. (NASDAQ:FENC): Are Analysts Optimistic? (Simply Wall St.)
Oct-17-22 08:00AM	Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United States (GlobeNewswire)
Sep-26-22 07:35AM	Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor (GlobeNewswire) -8.30%
Sep-21-22 02:19PM	RTP pharma to see $20M infusion on heels of drug winning approval (American City Business Journals) +11.93%
01:05PM	After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing Loss (Benzinga)
07:00AM	Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection) (GlobeNewswire)
06:05AM	U.S. FDA approves Fennec's hearing loss therapy (Reuters)
Aug-22-22 07:04AM	Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor (GlobeNewswire)
Aug-12-22 06:59AM	Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-22 02:59PM	RTP drugmaker secures up to $45M despite regulatory speed bumps (American City Business Journals)
07:30AM	Fennec Pharmaceuticals Announces Up to $45 Million Investment From Petrichor (GlobeNewswire)
Jul-10-22 08:42AM	What Kind Of Shareholders Own Fennec Pharmaceuticals Inc. (NASDAQ:FENC)? (Simply Wall St.)
Jun-14-22 06:00PM	Fennec Announces Results of Annual Meeting (GlobeNewswire)
May-23-22 07:29AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-12-22 06:00AM	Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
May-06-22 05:17PM	Inflation crushes market caps of Triangle's biggest public companies except these ones (American City Business Journals)
May-03-22 09:55AM	Can Adherex Technologies Inc. (FENC) Climb 92% to Reach the Level Wall Street Analysts Expect? (Zacks)
Apr-27-22 06:00AM	Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK (GlobeNewswire) -9.27%
Mar-25-22 07:00AM	Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference (GlobeNewswire)
Mar-24-22 06:00AM	Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark (GlobeNewswire) -6.41%
Feb-28-22 06:00AM	Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update (GlobeNewswire)
Jan-31-22 06:00AM	Fennec Pharmaceuticals Announces Management Change (GlobeNewswire) +5.20%
Jan-27-22 05:38PM	Hartford Financial Management Inc. Buys Exelon Corp, American Electric Power Co Inc, Pinnacle ... (GuruFocus.com) -7.54%
Dec-14-21 07:50PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC (ACCESSWIRE)
Dec-13-21 10:08AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC (PR Newswire)
Dec-01-21 07:06AM	RTP drugmaker suffers another regulatory setback (American City Business Journals) -11.39%
Nov-30-21 04:20PM	Fennec (FENC) Gets CRL From FDA for Pedmark, Stock Down (Zacks) -8.16%
10:57AM	FENC Fennec Pharmaceuticals Inc. Investors Who Have Lost More Than $25,000 Are Encouraged To Contact Kehoe Law Firm, P.C. Securities Class Action Investigation (GlobeNewswire)
06:00AM	Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors (GlobeNewswire)
05:49AM	When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Breakeven? (Simply Wall St.)
Nov-29-21 07:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC (GlobeNewswire) -50.41%
07:24AM	Fennec Pharmaceuticals Expects FDA Rejection for New Drug (Investing.com)
06:00AM	Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors (GlobeNewswire)
Nov-10-21 06:00AM	Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)
Oct-05-21 08:30AM	4 Breakout Stocks for Impressive Returns (Zacks)
Sep-29-21 02:27PM	Hedge Funds Are Piling Into Fennec Pharmaceuticals Inc. (FENC) (Insider Monkey)
Sep-09-21 06:00AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-10-21 06:00AM	Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update (GlobeNewswire)

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Raykov Rosty	Director	Dec 05 '24	Sale	6.04	796	4,808	66,432	Dec 05 04:24 PM
ROSTISLAV RAYKOV	Director	Dec 05 '24	Proposed Sale	6.04	796	4,808		Dec 05 04:00 PM
Raykov Rosty	Director	Dec 03 '24	Sale	6.13	1,635	10,023	67,228	Dec 04 05:20 PM
ROSTISLAV RAYKOV	Director	Dec 03 '24	Proposed Sale	6.13	1,635	10,023		Dec 03 04:03 PM
RALLIS CHRIS A	Director	Dec 02 '24	Option Exercise	2.69	10,000	26,900	58,623	Dec 02 07:07 PM
RALLIS CHRIS A	Director	Dec 02 '24	Sale	6.14	6,409	39,351	52,214	Dec 02 07:07 PM
CHRIS A RALLIS	Director	Dec 02 '24	Proposed Sale	6.14	6,409	39,344		Dec 02 04:06 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Nov 18 '24	Option Exercise	2.45	15,816	38,749	127,381	Nov 18 05:02 PM
Raykov Rosty	Director	Nov 04 '24	Sale	4.31	2,431	10,478	66,432	Nov 04 05:30 PM
ROSTISLAV RAYKOV	Director	Nov 04 '24	Proposed Sale	4.31	2,431	10,478		Nov 04 04:02 PM
RALLIS CHRIS A	Director	Oct 08 '24	Option Exercise	2.55	1,960	4,998	50,029	Oct 10 05:14 PM
RALLIS CHRIS A	Director	Oct 08 '24	Sale	4.53	1,406	6,369	48,623	Oct 10 05:14 PM
Raykov Rosty	Director	Oct 01 '24	Sale	4.94	2,431	12,009	66,432	Oct 01 05:11 PM
ROSTISLAV RAYKOV	Director	Oct 01 '24	Proposed Sale	4.94	2,431	12,009		Oct 01 04:07 PM
Haigh Adrian	Director	Sep 05 '24	Proposed Sale	5.00	20,246	101,230		Sep 05 05:02 PM
Raykov Rosty	Director	Sep 04 '24	Sale	5.52	2,431	13,419	66,432	Sep 04 06:48 PM
ROSTISLAV RAYKOV	Director	Sep 04 '24	Proposed Sale	5.52	2,431	13,419		Sep 04 04:05 PM
ROSTISLAV RAYKOV	Officer	Aug 01 '24	Proposed Sale	6.26	2,431	15,206		Aug 01 04:21 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Aug 01 '24	Sale	6.25	2,431	15,206	187,471	Aug 01 04:08 PM
RALLIS CHRIS A	Director	Jul 05 '24	Option Exercise	2.79	1,792	5,000	47,630	Jul 08 04:05 PM
RALLIS CHRIS A	Director	Jul 05 '24	Sale	6.03	1,173	7,073	46,457	Jul 08 04:05 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Jul 02 '24	Sale	6.13	2,431	14,902	187,471	Jul 02 05:55 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Jun 03 '24	Sale	6.76	2,431	16,434	187,471	Jun 03 05:12 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	May 01 '24	Sale	9.11	2,431	22,152	187,471	May 02 04:59 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 22 '24	Option Exercise	2.31	22,223	51,335	22,223	Apr 22 07:34 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 19 '24	Option Exercise	2.31	22,222	51,333	22,222	Apr 22 07:34 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 19 '24	Sale	9.34	22,222	207,442	0	Apr 22 07:34 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 22 '24	Sale	9.32	22,223	207,029	0	Apr 22 07:34 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 17 '24	Sale	9.91	22,222	220,220	22,222	Apr 18 09:43 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 18 '24	Sale	9.62	22,222	213,776	0	Apr 18 09:43 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 15 '24	Sale	10.30	22,222	228,793	22,222	Apr 16 06:00 PM
Haigh Adrian	CHIEF OPERATING OFFICER	Apr 16 '24	Sale	10.28	22,222	228,389	0	Apr 16 06:00 PM
RALLIS CHRIS A	Director	Apr 15 '24	Option Exercise	10.45	1,389	14,515	45,838	Apr 15 06:15 PM
RALLIS CHRIS A	Director	Apr 15 '24	Sale	10.45	800	8,360	44,449	Apr 15 06:15 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Apr 04 '24	Sale	10.89	44,283	482,400	231,771	Apr 05 04:56 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Apr 05 '24	Sale	10.75	44,300	476,269	187,471	Apr 05 04:56 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Apr 03 '24	Sale	10.78	40,584	437,451	276,054	Apr 03 05:37 PM
RALLIS CHRIS A	Director	Mar 26 '24	Option Exercise	2.31	4,329	10,000	45,249	Mar 27 04:24 PM
RALLIS CHRIS A	Director	Mar 26 '24	Sale	10.97	2,114	23,191	40,920	Mar 27 04:24 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Mar 26 '24	Sale	10.90	13,975	152,346	91,771	Mar 27 04:22 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Mar 25 '24	Sale	11.00	13,975	153,690	105,746	Mar 25 07:31 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Jan 04 '24	Sale	10.64	15,000	159,600	134,721	Jan 05 05:24 PM
Andrade Robert	CHIEF FINANCIAL OFFICER	Jan 05 '24	Sale	10.41	15,000	156,150	119,721	Jan 05 05:24 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Dec 28 '23	Option Exercise	1.59	8,540	13,579	291,127	Dec 29 04:30 PM
Raykov Rosty	CHIEF EXECUTIVE OFFICER	Dec 28 '23	Sale	11.55	3,656	42,227	287,471	Dec 29 04:30 PM
RALLIS CHRIS A	Director	Dec 26 '23	Option Exercise	1.59	3,144	4,999	46,178	Dec 28 04:02 PM
RALLIS CHRIS A	Director	Dec 26 '23	Sale	10.90	1,390	15,151	44,788	Dec 28 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FENC

Fennec Pharmaceuticals Inc

Upgrade your FINVIZ experience